ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Gregory Went on Q1 2019 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q1 2019 Earnings Conference Call
May 09, 2019, 16:30 ET
Company Participants
Peter Vozzo - Westwicke Partners
Gregory Went - Co-Founder, Chairman & CEO
Alfred Merriweather - CFO
Rajiv Patni - Chief Medical Officer
Conference Call Participants
Joshua Schimmer - Evercore ISI
Marc Goodman - SVB Leerink
Timothy Lugo - William Blair & Company
David Amsellem - Piper Jaffray Companies
Stacy Ku - Cowen and Company
Irina Koffler - Mizuho Securities
Tian Sun - Needham & Company
Jason Butler - JMP Securities
Presentation
Operator
Welcome to the Adamas Pharmaceuticals First Quarter